The Neonatal Adaptive Immune System

After completing this article, readers should be able to: 1. Describe the basic sequence of events that initiates an immune response. 2. Understand the basic differences between neonatal and adult T-cell function. 3. Describe the accumulation of maternal immunoglobulin G in the fetus. 4. Understand the barriers to strong B-cell function in the neonate. In 1960, the famous immunologist Peter Medawar was awarded a Nobel Prize for experiments describing the relative ease with which fetal immune systems develop tolerance to foreign antigens. (1) Neonates, therefore, were viewed as “immunodeficient,” and the neonatal period was believed to be a unique window in time during which any antigen encountered by the immune system would be tolerated and included in the repertoire of “self” antigens. However, more recent experiments have proven that, under the right conditions, the neonatal immune system generates responses similar in strength and quality to those of adults, leading some to speculate that when it comes to the immune system, there is “nothing special about the neonate.” (2) The truth lies somewhere in the middle of these two extreme views. The success of modern vaccination programs confirms that infants can mount significant immune responses. However, in the face of other immunologic challenges, such as group B streptococcal infections, infants demonstrate obvious weaknesses compared with adults. What do we know about the neonatal immune system? In what ways is it different from the adult immune system? What are the cellular and molecular mechanisms for these differences? This review summarizes the development of T- and B-cell immunity in the human neonate, with emphasis on the clinical implications of data. The adaptive immune system consists of T cells, B cells, and their products. (3) T cells are lymphocytes defined by their surface expression of the T-cell receptor (TCR) and are divided into subsets based on their surface …

[1]  Martin Catala,et al.  Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses. , 2005, Blood.

[2]  F. Powrie,et al.  Prenatal tolerance – a role for regulatory T cells? , 2005, European journal of immunology.

[3]  B. Blom,et al.  Development and activation of regulatory T cells in the human fetus , 2005, European journal of immunology.

[4]  G. Hodge,et al.  Potential immaturity of the T‐cell and antigen‐presenting cell interaction in cord blood with particular emphasis on the CD40‐CD40 ligand costimulatory pathway , 2004, Immunology.

[5]  C. Leclerc,et al.  Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.

[6]  J. Rodríguez-Sánchez,et al.  Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR , 2003, Journal of leukocyte biology.

[7]  S. Marshall‐Clarke,et al.  Functional responses of human neonatal B lymphocytes to antigen receptor cross‐linking and CpG DNA , 2003, Clinical and experimental immunology.

[8]  K. Dabbagh,et al.  Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation. , 2003, International immunology.

[9]  T. Tsurumi,et al.  Flow cytometric analysis of cytomegalovirus‐specific cell‐mediated immunity in the congenital infection , 2003, Journal of medical virology.

[10]  S. Schönland,et al.  Homeostatic control of T-cell generation in neonates. , 2003, Blood.

[11]  Y. Maldonado,et al.  Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. , 2003, Vaccine.

[12]  C. Siegrist.  Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. , 2003, Vaccine.

[13]  W. P. Glezen,et al.  Effect of maternal antibodies on the infant immune response. , 2003, Vaccine.

[14]  N. Simister.  Placental transport of immunoglobulin G. , 2003, Vaccine.

[15]  S. Rowland-Jones,et al.  Mature CD8(+) T lymphocyte response to viral infection during fetal life. , 2003, The Journal of clinical investigation.

[16]  P. Holt.  Functionally mature virus-specific CD8(+) T memory cells in congenitally infected newborns: proof of principle for neonatal vaccination? , 2003, The Journal of clinical investigation.

[17]  P. Lv,et al.  Phenotypic and functional analysis of human T lymphocytes in early second‐ and third‐trimester fetuses , 2002, Clinical and experimental immunology.

[18]  P. Holt,et al.  Differential Patterns of Methylation of the IFN-γ Promoter at CpG and Non-CpG Sites Underlie Differences in IFN-γ Gene Expression Between Human Neonatal and Adult CD45RO− T Cells1 , 2002, The Journal of Immunology.

[19]  S. Reich-Zeliger,et al.  T cells from newborn humans are fully capable of developing into cytotoxic T lymphocyte effector cells in adoptive hosts. , 2002, Transplantation.

[20]  C. Siegrist.  Neonatal and early life vaccinology. , 2001, Vaccine.

[21]  K. Sandberg,et al.  Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. , 2000, The Journal of pediatrics.

[22]  H. Hill,et al.  Additional confirmation of the lack of effect of intravenous immunoglobulin in the prevention of neonatal infection. , 2000, The Journal of pediatrics.

[23]  P. Holt,et al.  The development of the immune system during pregnancy and early life , 2000, Allergy.

[24]  W. Göpel,et al.  Maturational Changes of Lymphocyte Surface Antigens in Human Blood: Comparison between Fetuses, Neonates and Adults , 2000, Neonatology.

[25]  T. Lebien,et al.  Fates of human B-cell precursors. , 2000, Blood.

[26]  H. Van Bever,et al.  Determination of T‐cell subpopulations and intracellular cytokine production (interleukin‐2, interleukin‐4, and interferon‐γ) by cord blood T‐lymphocytes of neonates from atopic and non‐atopic parents , 2000, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[27]  M. Vitale,et al.  Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes. , 1999, Journal of immunology.

[28]  P. Sly,et al.  Development of allergen-specific T-cell memory in atopic and normal children , 1999, The Lancet.

[29]  Williams,et al.  Somatic mutation of immunoglobulin VH6 genes in human infants , 1998, Clinical and experimental immunology.

[30]  I. Katona,et al.  Characterization of Early Activation Events in Cord Blood B Cells after Stimulation with T Cell-Independent Activators , 1998, Pediatric Research.

[31]  J. Even,et al.  The Umbilical Cord Blood αβ T-Cell Repertoire: Characteristics of a Polyclonal and Naive but Completely Formed Repertoire , 1998 .

[32]  D. Reen,et al.  Cord blood CD4⊃ CD45RA⊃ T cells achieve a lower magnitude of activation when compared with their adult counterparts , 1997, Immunology.

[33]  P. Sly,et al.  Developing patterns of T cell memory to environmental allergens in the first two years of life. , 1997, International archives of allergy and immunology.

[34]  D Bourgeois,et al.  Photolysis of the Carbon Monoxide Complex of Myoglobin: Nanosecond Time-Resolved Crystallography , 1996, Science.

[35]  K. Nicolaides,et al.  Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy , 1996, American journal of reproductive immunology.

[36]  E. Pennisi.  Immunology: Teetering on the Brink of Danger , 1996 .

[37]  P. Matzinger,et al.  Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells , 1996, Science.

[38]  P. Lehmann,et al.  Induction of TH1 and TH2 Immunity in Neonatal Mice , 1996, Science.

[39]  M. Sarzotti,et al.  Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus , 1996, Science.

[40]  J. Gaddy,et al.  Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Franchimont,et al.  Defective Cytokine Expression but Adult-Type T-Cell Receptor, CD8, and p56lck Modulation in CD3− or CD2-Activated T Cells from Neonates , 1995, Pediatric Research.

[42]  J. Tyson,et al.  A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 1994, The New England journal of medicine.

[43]  M. Clerici,et al.  Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. , 1993, The Journal of clinical investigation.

[44]  D. Deluca,et al.  Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  I Hannet,et al.  Developmental and maturational changes in human blood lymphocyte subpopulations. , 1992, Immunology today.

[46]  Kendall A. Smith,et al.  Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory , 1991, The Journal of experimental medicine.

[47]  D. Lewis,et al.  Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. , 1991, The Journal of clinical investigation.

[48]  P. Medawar,et al.  ‘Actively Acquired Tolerance’ of Foreign Cells , 1953, Nature.